Pharmacovigilance – Products

Download this whitepaper to discover approaches for the detection and quantification of HCPs that streamline the process of impurity monitoring, have broad sample applicability through mass spectrometry and consider patient safety, product stability and purity.

APEIRON Biologics AG, a privately held biotech company developing breakthrough therapies to treat cancer and respiratory conditions, announced today that APN01 (alunacedase alfa) treatment showed statistically significant improvements in specific areas for severely ill COVID-19 patients.

Johnson & Johnson has announced topline efficacy and safety data from the Phase 3 ENSEMBLE trial. Results demonstrate that the investigational single-dose COVID-19 vaccine met all primary and key secondary endpoints. The level of protection against moderate to severe COVID-19 was 72% in the US, 66% in Latin America and 57% in South Africa, 28 days post-vaccination.

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

FDA publication demonstrates the advantages of PhysioMimix in drug safety and metabolism applications, over standard techniques.

A new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields is being developed by scientists, to regulate immune function.

Cybin Inc. today announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc.

Lonza today announced a collaboration with a global biopharma company. They both aim to commercialize antibody-drug conjugates.

DeepADMET have announced the successful conclusion of a new AI platform, to identify drug targets more efficiently.

InSphero AG, today announced the strengthening of its Scientific Advisory Board (SAB).